

![]() |
The role of cisapride in the treatment of pediatric gastroesophageal reflux. The European Society of Paediatric Gastroenterology, Hepatology and Nutrition |
|
Authors | ![]() | |
Published in | Journal of pediatric gastroenterology and nutrition. 1999, vol. 28, no. 5, p. 518-28 | |
Abstract | Cisapride is a gastrointestinal prokinetic agent that is used worldwide in the treatment of gastrointestinal motility-related disorders in premature infants, full-term infants, and children. Efficacy data suggest that it is the most effective commercially available prokinetic drug. | |
Keywords | Arrhythmias, Cardiac/chemically induced — Cisapride/administration & dosage/adverse effects/therapeutic use — Cytochrome P-450 CYP3A — Cytochrome P-450 Enzyme System/metabolism — Drug Interactions — Gastroesophageal Reflux/drug therapy — Gastrointestinal Agents/administration & dosage/adverse effects/therapeutic use — Humans — Infant — Infant, Newborn — Infant, Premature — Mixed Function Oxygenases/metabolism — Risk Factors | |
Identifiers | PMID: 10328131 | |
Full text | ||
Structures | ||
Research group | Gastroentérologie et transplantation (pédiatrie) (181) | |
Citation (ISO format) | VANDENPLAS, Y et al. The role of cisapride in the treatment of pediatric gastroesophageal reflux. The European Society of Paediatric Gastroenterology, Hepatology and Nutrition. In: Journal of pediatric gastroenterology and nutrition, 1999, vol. 28, n° 5, p. 518-28. https://archive-ouverte.unige.ch/unige:73880 |